Literature search results

2935 articles were found.

The following terms were included: Arzneimittel, Medikament, Pharmaka, pharmaceutical, medicament, drug, 薬剤の, 薬剤

• 2014, Tortella G, Selingardi PM, Moreno ML, Veronezi BP, Brunoni AR
  [details] Does non-invasive brain stimulation improve cognition in major depressive disorder? A systematic review [review]
  CNS Neurol Disord Drug Targets 13 (10): 1759-1769
• 2014, Lekner J
  Electroporation in cancer therapy without insertion of electrodes [tech./dosim.]
  Phys Med Biol 59 (20): 6031-6042
• 2014, Wocik-Piotrowicz K, Kaszuba-Zwoinska J, Rokita E, Thor P, Chrobik P, Nieckarz Z, Michalski J
  [details] Influence of static and alternating magnetic fields on U937 cell viability [med./bio.]
  Folia Med Cracov 54 (4): 21-33
• 2014, Azadarmaki R, Tubbs R, Chen DA, Shellock FG
  [details] MRI information for commonly used otologic implants: review and update [review]
  Otolaryngol Head Neck Surg 150 (4): 512-519
• 2014, Hong JM, Kang KS, Yi HG, Kim SY, Cho DW
  Electromagnetically controllable osteoclast activity [med./bio.]
  Bone 62: 99-107
• 2014, Schutter DJ, Sack AT
  [details] Current directions in non-invasive low intensity electric brain stimulation for depressive disorder [review]
  CNS Neurol Disord Drug Targets 13 (6): 945-952
• 2014, Wang Q, Wu W, Han X, Zheng A, Lei S, Wu J, Chen H, He C, Luo F, Liu X
  Osteogenic differentiation of amniotic epithelial cells: synergism of pulsed electromagnetic field and biochemical stimuli [med./bio.]
  BMC Musculoskelet Disord 15: 271
• 2014, Schetz D, Sein Anand J
  [Neurological disturbances in patient who ingested high doses of simvastatin] [foreign-language]
  Przegl Lek 71 (9): 499-501
• 2014, Thompson GL, Roth C, Tolstykh G, Kuipers M, Ibey BL
  Disruption of the actin cortex contributes to susceptibility of mammalian cells to nanosecond pulsed electric fields [med./bio.]
  Bioelectromagnetics 35 (4): 262-272
• 2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
  Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. app.]
  Cancer Med 3 (3): 592-602